

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 8.58709144 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 5.27119643 |
| 3 | platelet dense granule organization (GO:0060155) | 5.04513325 |
| 4 | definitive hemopoiesis (GO:0060216) | 5.03780226 |
| 5 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.90514909 |
| 6 | response to interferon-alpha (GO:0035455) | 4.79877585 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.75212006 |
| 8 | negative regulation of cell killing (GO:0031342) | 4.75212006 |
| 9 | response to interferon-beta (GO:0035456) | 4.72244556 |
| 10 | ribosomal small subunit assembly (GO:0000028) | 4.52094872 |
| 11 | response to peptidoglycan (GO:0032494) | 4.36048744 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 4.34049644 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.34049644 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.34049644 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.34049644 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 4.34049644 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 4.34049644 |
| 18 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.32240888 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.04510590 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 4.02459399 |
| 21 | endosome to pigment granule transport (GO:0043485) | 3.93096578 |
| 22 | endosome to melanosome transport (GO:0035646) | 3.93096578 |
| 23 | cellular response to type I interferon (GO:0071357) | 3.91312073 |
| 24 | type I interferon signaling pathway (GO:0060337) | 3.91312073 |
| 25 | detection of bacterium (GO:0016045) | 3.91238775 |
| 26 | immunoglobulin mediated immune response (GO:0016064) | 3.90711604 |
| 27 | response to type I interferon (GO:0034340) | 3.90588875 |
| 28 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.89578594 |
| 29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.84230246 |
| 30 | negative regulation of viral genome replication (GO:0045071) | 3.83101850 |
| 31 | megakaryocyte development (GO:0035855) | 3.81184946 |
| 32 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.78837428 |
| 33 | positive regulation of interferon-alpha production (GO:0032727) | 3.76057161 |
| 34 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.67974127 |
| 35 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.66532284 |
| 36 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.66267081 |
| 37 | B cell receptor signaling pathway (GO:0050853) | 3.63346249 |
| 38 | respiratory burst (GO:0045730) | 3.60243903 |
| 39 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.59650119 |
| 40 | mature B cell differentiation involved in immune response (GO:0002313) | 3.57549925 |
| 41 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.52079255 |
| 42 | regulation of interferon-alpha production (GO:0032647) | 3.52048467 |
| 43 | macrophage activation involved in immune response (GO:0002281) | 3.51748914 |
| 44 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.51601113 |
| 45 | neutrophil activation (GO:0042119) | 3.51313390 |
| 46 | myeloid cell activation involved in immune response (GO:0002275) | 3.48464451 |
| 47 | positive regulation of granulocyte differentiation (GO:0030854) | 3.47062434 |
| 48 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.46985346 |
| 49 | positive regulation of B cell differentiation (GO:0045579) | 3.46815334 |
| 50 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.43350866 |
| 51 | granulocyte activation (GO:0036230) | 3.43189347 |
| 52 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.41657869 |
| 53 | response to host immune response (GO:0052572) | 3.41657869 |
| 54 | negative regulation of interleukin-12 production (GO:0032695) | 3.39953039 |
| 55 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.37201324 |
| 56 | defense response to protozoan (GO:0042832) | 3.36381085 |
| 57 | detection of other organism (GO:0098543) | 3.35761937 |
| 58 | regulation of tolerance induction (GO:0002643) | 3.34552883 |
| 59 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.33832779 |
| 60 | leukocyte aggregation (GO:0070486) | 3.32906128 |
| 61 | regulation of mast cell activation (GO:0033003) | 3.32135050 |
| 62 | cellular extravasation (GO:0045123) | 3.31839104 |
| 63 | phagocytosis, engulfment (GO:0006911) | 3.31431929 |
| 64 | negative regulation of T cell mediated immunity (GO:0002710) | 3.30966221 |
| 65 | detection of biotic stimulus (GO:0009595) | 3.29474390 |
| 66 | detection of molecule of bacterial origin (GO:0032490) | 3.29470437 |
| 67 | regulation of platelet aggregation (GO:0090330) | 3.29380208 |
| 68 | negative thymic T cell selection (GO:0045060) | 3.28712071 |
| 69 | negative T cell selection (GO:0043383) | 3.28458380 |
| 70 | regulation of mast cell degranulation (GO:0043304) | 3.26039123 |
| 71 | tolerance induction (GO:0002507) | 3.24754362 |
| 72 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.23915980 |
| 73 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.23022707 |
| 74 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.21956491 |
| 75 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.19864665 |
| 76 | mast cell activation (GO:0045576) | 3.18366740 |
| 77 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.18159691 |
| 78 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.18159691 |
| 79 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.17768189 |
| 80 | negative regulation of interleukin-17 production (GO:0032700) | 3.16998897 |
| 81 | neutrophil mediated immunity (GO:0002446) | 3.16730659 |
| 82 | mature B cell differentiation (GO:0002335) | 3.16122048 |
| 83 | regulation of regulatory T cell differentiation (GO:0045589) | 3.16040187 |
| 84 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.14060427 |
| 85 | response to protozoan (GO:0001562) | 3.12855581 |
| 86 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.12635880 |
| 87 | positive regulation of interferon-beta production (GO:0032728) | 3.11613797 |
| 88 | positive thymic T cell selection (GO:0045059) | 3.11383373 |
| 89 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.09139880 |
| 90 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.07753502 |
| 91 | thrombin receptor signaling pathway (GO:0070493) | 3.07077931 |
| 92 | response to host (GO:0075136) | 3.07013060 |
| 93 | response to host defenses (GO:0052200) | 3.07013060 |
| 94 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.07013060 |
| 95 | response to interleukin-15 (GO:0070672) | 3.06578156 |
| 96 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.06184229 |
| 97 | regulation of leukocyte degranulation (GO:0043300) | 3.06009444 |
| 98 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.05894785 |
| 99 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.05894785 |
| 100 | secretory granule organization (GO:0033363) | 3.04128921 |
| 101 | activated T cell proliferation (GO:0050798) | 3.03206608 |
| 102 | response to muramyl dipeptide (GO:0032495) | 3.02422867 |
| 103 | polyketide metabolic process (GO:0030638) | 3.01676791 |
| 104 | doxorubicin metabolic process (GO:0044598) | 3.01676791 |
| 105 | daunorubicin metabolic process (GO:0044597) | 3.01676791 |
| 106 | regulation of germinal center formation (GO:0002634) | 3.00356874 |
| 107 | B cell mediated immunity (GO:0019724) | 3.00254595 |
| 108 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.00044414 |
| 109 | pinocytosis (GO:0006907) | 2.98921971 |
| 110 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.97357483 |
| 111 | positive regulation of mast cell activation (GO:0033005) | 2.96851398 |
| 112 | positive regulation of tolerance induction (GO:0002645) | 2.94999611 |
| 113 | regulation of B cell differentiation (GO:0045577) | 2.94478023 |
| 114 | myeloid dendritic cell activation (GO:0001773) | 2.94472986 |
| 115 | positive regulation of antigen processing and presentation (GO:0002579) | 2.92800554 |
| 116 | regulation of interleukin-17 production (GO:0032660) | 2.91162476 |
| 117 | negative regulation of viral entry into host cell (GO:0046597) | 2.90833284 |
| 118 | regulation of hypersensitivity (GO:0002883) | 2.90425449 |
| 119 | regulation of natural killer cell differentiation (GO:0032823) | 2.90158440 |
| 120 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.90099858 |
| 121 | T-helper 1 type immune response (GO:0042088) | 2.90025934 |
| 122 | positive regulation of B cell mediated immunity (GO:0002714) | 2.88976923 |
| 123 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.88976923 |
| 124 | T cell migration (GO:0072678) | 2.88547176 |
| 125 | detection of external biotic stimulus (GO:0098581) | 2.88344434 |
| 126 | positive regulation of macrophage differentiation (GO:0045651) | 2.88097535 |
| 127 | microglial cell activation (GO:0001774) | 2.87095774 |
| 128 | positive regulation of lymphocyte migration (GO:2000403) | 2.86292947 |
| 129 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.85633942 |
| 130 | regulation of platelet activation (GO:0010543) | 2.85608388 |
| 131 | dendritic cell migration (GO:0036336) | 2.84819882 |
| 132 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.84720267 |
| 133 | positive T cell selection (GO:0043368) | 2.84359068 |
| 134 | leukocyte degranulation (GO:0043299) | 2.83311332 |
| 135 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.83259984 |
| 136 | superoxide anion generation (GO:0042554) | 2.82478621 |
| 137 | myeloid leukocyte activation (GO:0002274) | 2.82349503 |
| 138 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.82263474 |
| 139 | positive regulation of interleukin-17 production (GO:0032740) | 2.81924243 |
| 140 | cellular response to interleukin-15 (GO:0071350) | 2.81710659 |
| 141 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.80334491 |
| 142 | positive regulation of mast cell degranulation (GO:0043306) | 2.80334491 |
| 143 | regulation of T cell tolerance induction (GO:0002664) | 2.80085692 |
| 144 | response to thyroid hormone (GO:0097066) | 2.79635064 |
| 145 | macrophage differentiation (GO:0030225) | 2.79279688 |
| 146 | cellular response to interferon-beta (GO:0035458) | 2.79264384 |
| 147 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.77640159 |
| 148 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.77632091 |
| 149 | lymph node development (GO:0048535) | 2.77212628 |
| 150 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.77087473 |
| 151 | macrophage activation (GO:0042116) | 2.75653305 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.58390910 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.67544793 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.42872585 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.54731813 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.36236157 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.94479177 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.94156743 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.91620681 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.44101060 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.36014468 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.31514804 |
| 12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.22734434 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.11556163 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.09390974 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.96233364 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.91805560 |
| 17 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.72032948 |
| 18 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.56901240 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.35342602 |
| 20 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.31707095 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.29801043 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.26240557 |
| 23 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.26025563 |
| 24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22628028 |
| 25 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19720363 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.12097310 |
| 27 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.08795536 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.01356419 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.96380109 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93485511 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.88950525 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.85987273 |
| 33 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.84715322 |
| 34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.78236736 |
| 35 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.76396369 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.75439322 |
| 37 | MYB_26560356_Chip-Seq_TH2_Human | 1.71422739 |
| 38 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.70431199 |
| 39 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.67810066 |
| 40 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.67146098 |
| 41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66024542 |
| 42 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.65320659 |
| 43 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.58412889 |
| 44 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.55593889 |
| 45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.55408117 |
| 46 | GATA1_22025678_ChIP-Seq_K562_Human | 1.51594986 |
| 47 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45973932 |
| 48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.44962277 |
| 49 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43386852 |
| 50 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.43102793 |
| 51 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.42222414 |
| 52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.41815023 |
| 53 | MYB_26560356_Chip-Seq_TH1_Human | 1.38125889 |
| 54 | MAF_26560356_Chip-Seq_TH1_Human | 1.37471179 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35432999 |
| 56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.34997990 |
| 57 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.34060171 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.33834555 |
| 59 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.31924508 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29668411 |
| 61 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27940980 |
| 62 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25412592 |
| 63 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.24873665 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22905630 |
| 65 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21788675 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20794989 |
| 67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17430625 |
| 68 | GATA3_26560356_Chip-Seq_TH2_Human | 1.15017762 |
| 69 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.11102986 |
| 70 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.09830087 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08015330 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06510618 |
| 73 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04368715 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04278099 |
| 75 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.03876696 |
| 76 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.01364807 |
| 77 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00493780 |
| 78 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00081224 |
| 79 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99933088 |
| 80 | UTX_26944678_Chip-Seq_JUKART_Human | 0.99292916 |
| 81 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98066255 |
| 82 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96885610 |
| 83 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.95581787 |
| 84 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.94607418 |
| 85 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93857906 |
| 86 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.91962961 |
| 87 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.91055917 |
| 88 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91036776 |
| 89 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.90659911 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90005890 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89288234 |
| 92 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88031307 |
| 93 | MAF_26560356_Chip-Seq_TH2_Human | 0.87612457 |
| 94 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.84895106 |
| 95 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.83607266 |
| 96 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.83455474 |
| 97 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81386735 |
| 98 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80989629 |
| 99 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.80839880 |
| 100 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.80482600 |
| 101 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.80229799 |
| 102 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.79839161 |
| 103 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.79053282 |
| 104 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.77604695 |
| 105 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.76953609 |
| 106 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76747479 |
| 107 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.76130023 |
| 108 | GATA3_26560356_Chip-Seq_TH1_Human | 0.75999229 |
| 109 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75349424 |
| 110 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.74930984 |
| 111 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74804086 |
| 112 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.72483304 |
| 113 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72116907 |
| 114 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.71962588 |
| 115 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.71913565 |
| 116 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.69010432 |
| 117 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.68959178 |
| 118 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.68751845 |
| 119 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.68118585 |
| 120 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.67956341 |
| 121 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.67956341 |
| 122 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67564792 |
| 123 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.66507010 |
| 124 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.65658733 |
| 125 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.61509492 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.04603665 |
| 2 | MP0003436_decreased_susceptibility_to | 3.69774151 |
| 3 | MP0009785_altered_susceptibility_to | 3.45161501 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.42055082 |
| 5 | MP0003724_increased_susceptibility_to | 3.40284108 |
| 6 | MP0002419_abnormal_innate_immunity | 3.07716063 |
| 7 | MP0005464_abnormal_platelet_physiology | 2.92737826 |
| 8 | MP0005025_abnormal_response_to | 2.81943179 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.80463389 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.55228773 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.51645918 |
| 12 | MP0005174_abnormal_tail_pigmentation | 2.48792683 |
| 13 | MP0005671_abnormal_response_to | 2.46650284 |
| 14 | MP0000685_abnormal_immune_system | 2.46294433 |
| 15 | MP0006082_CNS_inflammation | 2.34994454 |
| 16 | MP0002723_abnormal_immune_serum | 2.29254558 |
| 17 | MP0001800_abnormal_humoral_immune | 2.27009606 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.26651689 |
| 19 | MP0004808_abnormal_hematopoietic_stem | 2.24930240 |
| 20 | MP0000343_altered_response_to | 2.20065978 |
| 21 | MP0001790_abnormal_immune_system | 2.17404071 |
| 22 | MP0005387_immune_system_phenotype | 2.17404071 |
| 23 | MP0001819_abnormal_immune_cell | 2.16804784 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.16793867 |
| 25 | MP0009278_abnormal_bone_marrow | 2.12259978 |
| 26 | MP0000465_gastrointestinal_hemorrhage | 2.09614934 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 2.09582563 |
| 28 | MP0001533_abnormal_skeleton_physiology | 2.08939841 |
| 29 | MP0002396_abnormal_hematopoietic_system | 2.01684999 |
| 30 | MP0005397_hematopoietic_system_phenotyp | 1.93322285 |
| 31 | MP0001545_abnormal_hematopoietic_system | 1.93322285 |
| 32 | MP0003303_peritoneal_inflammation | 1.89747601 |
| 33 | MP0004510_myositis | 1.88005028 |
| 34 | MP0001853_heart_inflammation | 1.76522371 |
| 35 | MP0002405_respiratory_system_inflammati | 1.75775658 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.70050540 |
| 37 | MP0003075_altered_response_to | 1.68348963 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.67033342 |
| 39 | MP0003279_aneurysm | 1.64604270 |
| 40 | MP0009764_decreased_sensitivity_to | 1.62646398 |
| 41 | MP0003828_pulmonary_edema | 1.62525948 |
| 42 | MP0002398_abnormal_bone_marrow | 1.60844449 |
| 43 | MP0000716_abnormal_immune_system | 1.60292295 |
| 44 | MP0003183_abnormal_peptide_metabolism | 1.55537768 |
| 45 | MP0000689_abnormal_spleen_morphology | 1.52257046 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.52186249 |
| 47 | MP0008469_abnormal_protein_level | 1.50673498 |
| 48 | MP0001958_emphysema | 1.43739909 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 1.42867240 |
| 50 | MP0010368_abnormal_lymphatic_system | 1.39148018 |
| 51 | MP0002429_abnormal_blood_cell | 1.37798658 |
| 52 | MP0000703_abnormal_thymus_morphology | 1.37626345 |
| 53 | MP0002166_altered_tumor_susceptibility | 1.36525916 |
| 54 | MP0002006_tumorigenesis | 1.34508521 |
| 55 | MP0000015_abnormal_ear_pigmentation | 1.33676329 |
| 56 | MP0000490_abnormal_crypts_of | 1.32678793 |
| 57 | MP0008438_abnormal_cutaneous_collagen | 1.30814428 |
| 58 | MP0002722_abnormal_immune_system | 1.30254236 |
| 59 | MP0005166_decreased_susceptibility_to | 1.26292565 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.23949842 |
| 61 | MP0005390_skeleton_phenotype | 1.23540119 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 1.22583881 |
| 63 | MP0004947_skin_inflammation | 1.22072829 |
| 64 | MP0003448_altered_tumor_morphology | 1.21892401 |
| 65 | MP0002095_abnormal_skin_pigmentation | 1.20737897 |
| 66 | MP0002933_joint_inflammation | 1.18273010 |
| 67 | MP0005164_abnormal_response_to | 1.18130786 |
| 68 | MP0004381_abnormal_hair_follicle | 1.16828468 |
| 69 | MP0006054_spinal_hemorrhage | 1.16454100 |
| 70 | MP0001879_abnormal_lymphatic_vessel | 1.12887100 |
| 71 | MP0005310_abnormal_salivary_gland | 1.12755068 |
| 72 | MP0009379_abnormal_foot_pigmentation | 1.04851020 |
| 73 | MP0000569_abnormal_digit_pigmentation | 1.04487110 |
| 74 | MP0008260_abnormal_autophagy | 1.02242154 |
| 75 | MP0000372_irregular_coat_pigmentation | 0.96814633 |
| 76 | MP0005075_abnormal_melanosome_morpholog | 0.94765696 |
| 77 | MP0001851_eye_inflammation | 0.94762363 |
| 78 | MP0003690_abnormal_glial_cell | 0.91534004 |
| 79 | MP0009763_increased_sensitivity_to | 0.91473922 |
| 80 | MP0003045_fibrosis | 0.90493982 |
| 81 | MP0004883_abnormal_blood_vessel | 0.89873678 |
| 82 | MP0000858_altered_metastatic_potential | 0.89601294 |
| 83 | MP0000249_abnormal_blood_vessel | 0.89568639 |
| 84 | MP0002877_abnormal_melanocyte_morpholog | 0.89091767 |
| 85 | MP0001986_abnormal_taste_sensitivity | 0.88790903 |
| 86 | MP0008004_abnormal_stomach_pH | 0.87708960 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.86766856 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.86627780 |
| 89 | MP0004130_abnormal_muscle_cell | 0.86447160 |
| 90 | MP0000767_abnormal_smooth_muscle | 0.85610633 |
| 91 | MP0005084_abnormal_gallbladder_morpholo | 0.79679567 |
| 92 | MP0002132_abnormal_respiratory_system | 0.79313776 |
| 93 | MP0005083_abnormal_biliary_tract | 0.77230217 |
| 94 | MP0003866_abnormal_defecation | 0.77149385 |
| 95 | MP0002277_abnormal_respiratory_mucosa | 0.75769589 |
| 96 | MP0003795_abnormal_bone_structure | 0.75694138 |
| 97 | MP0003943_abnormal_hepatobiliary_system | 0.75332610 |
| 98 | MP0004782_abnormal_surfactant_physiolog | 0.74298887 |
| 99 | MP0003011_delayed_dark_adaptation | 0.73954939 |
| 100 | MP0003136_yellow_coat_color | 0.73381989 |
| 101 | MP0003566_abnormal_cell_adhesion | 0.71148915 |
| 102 | MP0001873_stomach_inflammation | 0.70091236 |
| 103 | MP0001765_abnormal_ion_homeostasis | 0.69318518 |
| 104 | MP0000230_abnormal_systemic_arterial | 0.69168257 |
| 105 | MP0003252_abnormal_bile_duct | 0.67543473 |
| 106 | MP0004484_altered_response_of | 0.67326820 |
| 107 | MP0000371_diluted_coat_color | 0.66654701 |
| 108 | MP0009840_abnormal_foam_cell | 0.66485754 |
| 109 | MP0005409_darkened_coat_color | 0.65463280 |
| 110 | MP0001663_abnormal_digestive_system | 0.65364093 |
| 111 | MP0003300_gastrointestinal_ulcer | 0.65111839 |
| 112 | MP0004147_increased_porphyrin_level | 0.64681222 |
| 113 | MP0002009_preneoplasia | 0.63903732 |
| 114 | MP0003806_abnormal_nucleotide_metabolis | 0.62630828 |
| 115 | MP0003638_abnormal_response/metabolism_ | 0.62330379 |
| 116 | MP0003186_abnormal_redox_activity | 0.61652644 |
| 117 | MP0002019_abnormal_tumor_incidence | 0.56715183 |
| 118 | MP0009642_abnormal_blood_homeostasis | 0.54001591 |
| 119 | MP0008874_decreased_physiological_sensi | 0.53465877 |
| 120 | MP0005535_abnormal_body_temperature | 0.52890592 |
| 121 | MP0002136_abnormal_kidney_physiology | 0.51573789 |
| 122 | MP0005381_digestive/alimentary_phenotyp | 0.49447379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.58104898 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.87822225 |
| 3 | Myositis (HP:0100614) | 4.96335856 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 4.95153957 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.93611757 |
| 6 | Abnormality of macrophages (HP:0004311) | 4.69835254 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.62652446 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 4.54163438 |
| 9 | Prolonged bleeding time (HP:0003010) | 4.49243658 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.33884307 |
| 11 | Thrombocytosis (HP:0001894) | 3.95816563 |
| 12 | Orchitis (HP:0100796) | 3.87328271 |
| 13 | Recurrent skin infections (HP:0001581) | 3.79786042 |
| 14 | Increased mean platelet volume (HP:0011877) | 3.74275658 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 3.71399442 |
| 16 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.69965383 |
| 17 | Absent/shortened dynein arms (HP:0200106) | 3.69965383 |
| 18 | Petechiae (HP:0000967) | 3.57416651 |
| 19 | Cellulitis (HP:0100658) | 3.49302584 |
| 20 | T lymphocytopenia (HP:0005403) | 3.44516233 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 3.41803006 |
| 22 | Optic neuritis (HP:0100653) | 3.41803006 |
| 23 | Obstructive lung disease (HP:0006536) | 3.40176930 |
| 24 | Chronic obstructive pulmonary disease (HP:0006510) | 3.40176930 |
| 25 | Epistaxis (HP:0000421) | 3.34963260 |
| 26 | Gastrointestinal infarctions (HP:0005244) | 3.34647092 |
| 27 | Abnormality of T cell number (HP:0011839) | 3.34320815 |
| 28 | Spontaneous hematomas (HP:0007420) | 3.34053975 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.33275355 |
| 30 | Abnormal ciliary motility (HP:0012262) | 3.28382330 |
| 31 | Prostate neoplasm (HP:0100787) | 3.20232120 |
| 32 | Purpura (HP:0000979) | 3.19766013 |
| 33 | Mediastinal lymphadenopathy (HP:0100721) | 3.18251844 |
| 34 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.17740044 |
| 35 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.17740044 |
| 36 | Chest pain (HP:0100749) | 3.16620631 |
| 37 | Glomerulonephritis (HP:0000099) | 3.07778852 |
| 38 | Recurrent fungal infections (HP:0002841) | 3.05832091 |
| 39 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.99939219 |
| 40 | Impaired platelet aggregation (HP:0003540) | 2.99837382 |
| 41 | Abnormal platelet function (HP:0011869) | 2.99837382 |
| 42 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.89622961 |
| 43 | IgM deficiency (HP:0002850) | 2.88357344 |
| 44 | Leukocytosis (HP:0001974) | 2.86586844 |
| 45 | Dysostosis multiplex (HP:0000943) | 2.86464990 |
| 46 | Increased IgM level (HP:0003496) | 2.80295027 |
| 47 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.80013098 |
| 48 | Menorrhagia (HP:0000132) | 2.77207893 |
| 49 | Periodontitis (HP:0000704) | 2.76999030 |
| 50 | Gingival bleeding (HP:0000225) | 2.76080475 |
| 51 | Abnormality of T cells (HP:0002843) | 2.75326780 |
| 52 | Gingivitis (HP:0000230) | 2.72725016 |
| 53 | Arterial thrombosis (HP:0004420) | 2.71945257 |
| 54 | Albinism (HP:0001022) | 2.71364466 |
| 55 | Meningitis (HP:0001287) | 2.69103360 |
| 56 | Disinhibition (HP:0000734) | 2.65362017 |
| 57 | Autoimmune hemolytic anemia (HP:0001890) | 2.64431258 |
| 58 | Interstitial pulmonary disease (HP:0006530) | 2.55317474 |
| 59 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.55028422 |
| 60 | Loss of speech (HP:0002371) | 2.53625978 |
| 61 | Recurrent viral infections (HP:0004429) | 2.50470655 |
| 62 | Vasculitis (HP:0002633) | 2.49484626 |
| 63 | Abnormality of the prostate (HP:0008775) | 2.49289134 |
| 64 | Nasal polyposis (HP:0100582) | 2.48678297 |
| 65 | Chronic otitis media (HP:0000389) | 2.46340827 |
| 66 | Recurrent cutaneous fungal infections (HP:0011370) | 2.45362003 |
| 67 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.45362003 |
| 68 | Granulocytopenia (HP:0001913) | 2.44757145 |
| 69 | Episodic fever (HP:0001954) | 2.43663001 |
| 70 | Pustule (HP:0200039) | 2.42946201 |
| 71 | Vertebral compression fractures (HP:0002953) | 2.42587410 |
| 72 | Recurrent sinusitis (HP:0011108) | 2.40658285 |
| 73 | Bronchiectasis (HP:0002110) | 2.39358750 |
| 74 | Spinal cord lesions (HP:0100561) | 2.39145363 |
| 75 | Syringomyelia (HP:0003396) | 2.39145363 |
| 76 | Recurrent bronchitis (HP:0002837) | 2.39008870 |
| 77 | Gangrene (HP:0100758) | 2.38699141 |
| 78 | Bruising susceptibility (HP:0000978) | 2.37752121 |
| 79 | Rhinitis (HP:0012384) | 2.37383084 |
| 80 | Joint hemorrhage (HP:0005261) | 2.37218281 |
| 81 | Eosinophilia (HP:0001880) | 2.34273257 |
| 82 | Increased IgE level (HP:0003212) | 2.33087612 |
| 83 | Axonal loss (HP:0003447) | 2.32716349 |
| 84 | Autoimmune thrombocytopenia (HP:0001973) | 2.28860631 |
| 85 | Stomatitis (HP:0010280) | 2.28196279 |
| 86 | Inflammation of the large intestine (HP:0002037) | 2.28017535 |
| 87 | Hematochezia (HP:0002573) | 2.27959213 |
| 88 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.26187745 |
| 89 | Joint swelling (HP:0001386) | 2.25611500 |
| 90 | Anorexia (HP:0002039) | 2.25271507 |
| 91 | Osteomyelitis (HP:0002754) | 2.24113493 |
| 92 | Vertigo (HP:0002321) | 2.24107594 |
| 93 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.21357560 |
| 94 | Mucopolysacchariduria (HP:0008155) | 2.21357560 |
| 95 | Amyloidosis (HP:0011034) | 2.20764568 |
| 96 | Beaking of vertebral bodies (HP:0004568) | 2.19836047 |
| 97 | Hypochromic microcytic anemia (HP:0004840) | 2.18484672 |
| 98 | Urticaria (HP:0001025) | 2.18377993 |
| 99 | Chronic sinusitis (HP:0011109) | 2.18143064 |
| 100 | Peritonitis (HP:0002586) | 2.15518301 |
| 101 | Abnormal platelet volume (HP:0011876) | 2.14533992 |
| 102 | Nonprogressive disorder (HP:0003680) | 2.14483366 |
| 103 | Hyperlipoproteinemia (HP:0010980) | 2.13816965 |
| 104 | Gastrointestinal inflammation (HP:0004386) | 2.12303981 |
| 105 | Abnormality of T cell physiology (HP:0011840) | 2.11648865 |
| 106 | Colitis (HP:0002583) | 2.11508177 |
| 107 | Recurrent lower respiratory tract infections (HP:0002783) | 2.10810595 |
| 108 | Keratoconjunctivitis sicca (HP:0001097) | 2.10194399 |
| 109 | Thrombophlebitis (HP:0004418) | 2.10171533 |
| 110 | Abnormality of eosinophils (HP:0001879) | 2.09076057 |
| 111 | Abnormality of the pleura (HP:0002103) | 2.08965467 |
| 112 | Agnosia (HP:0010524) | 2.08746837 |
| 113 | Abnormality of iron homeostasis (HP:0011031) | 2.07955062 |
| 114 | Hypergammaglobulinemia (HP:0010702) | 2.07830744 |
| 115 | Nephritis (HP:0000123) | 2.07190683 |
| 116 | Agammaglobulinemia (HP:0004432) | 2.07098441 |
| 117 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.06072440 |
| 118 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.06072440 |
| 119 | Abnormality of glycolipid metabolism (HP:0010969) | 2.06072440 |
| 120 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.04210809 |
| 121 | Bronchitis (HP:0012387) | 2.03862777 |
| 122 | Encephalitis (HP:0002383) | 2.03378276 |
| 123 | Recurrent pneumonia (HP:0006532) | 2.03359743 |
| 124 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.01805078 |
| 125 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.01651089 |
| 126 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.01651089 |
| 127 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.01651089 |
| 128 | Microcytic anemia (HP:0001935) | 2.01319441 |
| 129 | Conjunctival telangiectasia (HP:0000524) | 2.01244684 |
| 130 | Hepatosplenomegaly (HP:0001433) | 1.99381919 |
| 131 | Pulmonary embolism (HP:0002204) | 1.99223381 |
| 132 | Abnormality of the nasal mucosa (HP:0000433) | 1.97675147 |
| 133 | Amaurosis fugax (HP:0100576) | 1.96751921 |
| 134 | Patchy hypopigmentation of hair (HP:0011365) | 1.96578486 |
| 135 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.95721725 |
| 136 | Osteolytic defects of the hand bones (HP:0009699) | 1.95721725 |
| 137 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.95168592 |
| 138 | Basal ganglia calcification (HP:0002135) | 1.92338432 |
| 139 | Spondylolisthesis (HP:0003302) | 1.91664506 |
| 140 | Panhypogammaglobulinemia (HP:0003139) | 1.91301316 |
| 141 | Hemoptysis (HP:0002105) | 1.88808158 |
| 142 | Gastrointestinal stroma tumor (HP:0100723) | 1.88450435 |
| 143 | Keratoconjunctivitis (HP:0001096) | 1.85688669 |
| 144 | Pulmonary infiltrates (HP:0002113) | 1.84692726 |
| 145 | Abnormality of the lumbar spine (HP:0100712) | 1.84281079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 3.27078048 |
| 2 | RIPK4 | 3.24401803 |
| 3 | IRAK4 | 3.11911600 |
| 4 | KIT | 3.01439999 |
| 5 | TIE1 | 2.88800375 |
| 6 | MUSK | 2.80460630 |
| 7 | BLK | 2.59967476 |
| 8 | MAP3K14 | 2.55182335 |
| 9 | MAP4K1 | 2.49387404 |
| 10 | GRK6 | 2.36038191 |
| 11 | TBK1 | 2.31761781 |
| 12 | BTK | 2.19615985 |
| 13 | TXK | 2.17720128 |
| 14 | TEC | 2.17571273 |
| 15 | NME2 | 2.07285184 |
| 16 | TGFBR1 | 2.04480042 |
| 17 | IKBKE | 1.97502327 |
| 18 | MAP3K12 | 1.94800614 |
| 19 | MAP3K13 | 1.89947166 |
| 20 | TYK2 | 1.89721884 |
| 21 | IKBKB | 1.84312874 |
| 22 | PIM2 | 1.82703697 |
| 23 | MAP2K3 | 1.75793985 |
| 24 | JAK3 | 1.73747924 |
| 25 | IRAK3 | 1.73515476 |
| 26 | GRK7 | 1.71433278 |
| 27 | MATK | 1.69011166 |
| 28 | ITK | 1.68750426 |
| 29 | FES | 1.62581267 |
| 30 | ZAP70 | 1.53785624 |
| 31 | CSF1R | 1.52797302 |
| 32 | TRPM7 | 1.50726367 |
| 33 | FRK | 1.50029529 |
| 34 | HCK | 1.38277784 |
| 35 | SYK | 1.36303370 |
| 36 | ADRBK2 | 1.33017857 |
| 37 | PTK2B | 1.32120750 |
| 38 | LYN | 1.32109055 |
| 39 | MAPKAPK5 | 1.20371290 |
| 40 | MYLK | 1.17912684 |
| 41 | ERN1 | 1.14799331 |
| 42 | CDK19 | 1.14625747 |
| 43 | LCK | 1.14143151 |
| 44 | TAOK3 | 1.11741545 |
| 45 | CLK1 | 1.06427664 |
| 46 | MKNK1 | 1.06047598 |
| 47 | TNIK | 1.02602278 |
| 48 | PIM1 | 1.00645576 |
| 49 | NEK9 | 1.00413014 |
| 50 | CAMKK2 | 0.99774034 |
| 51 | MARK3 | 0.99251856 |
| 52 | MOS | 0.98682266 |
| 53 | CSK | 0.95996924 |
| 54 | EPHB1 | 0.90900592 |
| 55 | TNK2 | 0.90701458 |
| 56 | PDK1 | 0.87894935 |
| 57 | PRPF4B | 0.87882519 |
| 58 | JAK1 | 0.85710083 |
| 59 | PAK4 | 0.85306602 |
| 60 | PRKCQ | 0.84970716 |
| 61 | PRKG2 | 0.84544962 |
| 62 | CHUK | 0.79962803 |
| 63 | YES1 | 0.78066238 |
| 64 | TLK1 | 0.77759249 |
| 65 | SIK3 | 0.76321232 |
| 66 | EIF2AK2 | 0.74676297 |
| 67 | GRK5 | 0.74243671 |
| 68 | STK10 | 0.74125238 |
| 69 | MAP3K2 | 0.73960247 |
| 70 | CDK8 | 0.73272345 |
| 71 | BMPR1B | 0.72199978 |
| 72 | MAP3K5 | 0.69480591 |
| 73 | LRRK2 | 0.68267989 |
| 74 | BMX | 0.67134007 |
| 75 | PBK | 0.66766832 |
| 76 | EEF2K | 0.66019834 |
| 77 | FLT3 | 0.65689799 |
| 78 | KDR | 0.65377287 |
| 79 | MAP3K1 | 0.64770985 |
| 80 | MAP3K6 | 0.64597817 |
| 81 | RIPK1 | 0.61873670 |
| 82 | FGR | 0.61702104 |
| 83 | PIK3CG | 0.61115959 |
| 84 | ACVR1B | 0.61048901 |
| 85 | PDPK1 | 0.60898383 |
| 86 | CAMK1D | 0.60704677 |
| 87 | PIK3CA | 0.60357024 |
| 88 | JAK2 | 0.59854202 |
| 89 | PRKCD | 0.58852180 |
| 90 | MAPK12 | 0.57635723 |
| 91 | NUAK1 | 0.56868161 |
| 92 | MAP2K6 | 0.56601789 |
| 93 | ABL1 | 0.56601659 |
| 94 | STK24 | 0.55458152 |
| 95 | MAP3K7 | 0.55339099 |
| 96 | NLK | 0.55141228 |
| 97 | ADRBK1 | 0.54170134 |
| 98 | TAOK1 | 0.54009622 |
| 99 | FGFR3 | 0.53071561 |
| 100 | IRAK1 | 0.53066731 |
| 101 | MAPK15 | 0.52994516 |
| 102 | MAPK7 | 0.52698713 |
| 103 | MARK2 | 0.51348736 |
| 104 | RPS6KA6 | 0.50857561 |
| 105 | GRK1 | 0.49518924 |
| 106 | EPHA3 | 0.49008318 |
| 107 | IRAK2 | 0.48386134 |
| 108 | ARAF | 0.46460863 |
| 109 | MST1R | 0.46211396 |
| 110 | IGF1R | 0.43588233 |
| 111 | RPS6KA5 | 0.42520818 |
| 112 | BCKDK | 0.42064603 |
| 113 | PKN2 | 0.41749308 |
| 114 | ERBB2 | 0.41728614 |
| 115 | TAOK2 | 0.41589776 |
| 116 | RPS6KB2 | 0.41298775 |
| 117 | MAP3K3 | 0.39521127 |
| 118 | BMPR2 | 0.39411961 |
| 119 | ILK | 0.39199520 |
| 120 | RPS6KA4 | 0.38427838 |
| 121 | EGFR | 0.37165473 |
| 122 | DAPK2 | 0.36853283 |
| 123 | OXSR1 | 0.36683376 |
| 124 | ABL2 | 0.36653840 |
| 125 | HIPK2 | 0.36610558 |
| 126 | FYN | 0.36418896 |
| 127 | STK4 | 0.36316577 |
| 128 | RET | 0.36284919 |
| 129 | SGK2 | 0.36176368 |
| 130 | PRKD1 | 0.35884190 |
| 131 | CAMK1 | 0.34878059 |
| 132 | SIK2 | 0.32981432 |
| 133 | MST4 | 0.32928059 |
| 134 | ERBB3 | 0.32314388 |
| 135 | MAP3K11 | 0.32280999 |
| 136 | CAMKK1 | 0.30904743 |
| 137 | TESK2 | 0.30839262 |
| 138 | TTN | 0.30551344 |
| 139 | RAF1 | 0.29748706 |
| 140 | MAPK4 | 0.29410580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.14506455 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.11547238 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.44033143 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.41851953 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.37078357 |
| 6 | Pertussis_Homo sapiens_hsa05133 | 2.35331743 |
| 7 | Malaria_Homo sapiens_hsa05144 | 2.23050292 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.22791153 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.16129151 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 2.10802878 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.05090532 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.03962988 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.01453241 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 1.93446825 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.91899521 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.90440188 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.88670289 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.88212744 |
| 19 | Ribosome_Homo sapiens_hsa03010 | 1.82395940 |
| 20 | Salmonella infection_Homo sapiens_hsa05132 | 1.77763237 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.76747446 |
| 22 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.75234935 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.74788610 |
| 24 | Platelet activation_Homo sapiens_hsa04611 | 1.74738863 |
| 25 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.69769916 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.69419766 |
| 27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.60864941 |
| 28 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.55270912 |
| 29 | Phagosome_Homo sapiens_hsa04145 | 1.52415034 |
| 30 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.46450132 |
| 31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.46247267 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.44430763 |
| 33 | Asthma_Homo sapiens_hsa05310 | 1.42000910 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.39244040 |
| 35 | Allograft rejection_Homo sapiens_hsa05330 | 1.34201969 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33882652 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.31783324 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.29646971 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.28204601 |
| 40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.28029846 |
| 41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21766414 |
| 42 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.20145156 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.19528342 |
| 44 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.14543337 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13172911 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12423259 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 1.11218404 |
| 48 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.08976945 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.07901171 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07743086 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.06520240 |
| 52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.04256266 |
| 53 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.04118797 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.02160151 |
| 55 | Hepatitis B_Homo sapiens_hsa05161 | 1.00756970 |
| 56 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99387922 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.90363199 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87850560 |
| 59 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.87102294 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.86577233 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.86093756 |
| 62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.85756436 |
| 63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.84412231 |
| 64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.79887888 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78439671 |
| 66 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.75200854 |
| 67 | Amoebiasis_Homo sapiens_hsa05146 | 0.71969092 |
| 68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.71720705 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66317853 |
| 70 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62093854 |
| 71 | Protein export_Homo sapiens_hsa03060 | 0.61358261 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60325808 |
| 73 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59565841 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59279234 |
| 75 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58953357 |
| 76 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58884144 |
| 77 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54739229 |
| 78 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.53706010 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53207929 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50823071 |
| 81 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50104982 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50067054 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.48515141 |
| 84 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47974781 |
| 85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.47820080 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47425543 |
| 87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.47379836 |
| 88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46951573 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46374277 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44575353 |
| 91 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.44106561 |
| 92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43503596 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42852803 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41975129 |
| 95 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.41887324 |
| 96 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.41863582 |
| 97 | Viral myocarditis_Homo sapiens_hsa05416 | 0.40827454 |
| 98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.40479928 |
| 99 | Olfactory transduction_Homo sapiens_hsa04740 | 0.39743149 |
| 100 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.39662127 |
| 101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39647720 |
| 102 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.39012529 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37289341 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36643971 |
| 105 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.34076082 |
| 106 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.33454863 |
| 107 | HTLV-I infection_Homo sapiens_hsa05166 | 0.32083553 |
| 108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.31831650 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31646598 |
| 110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.31429441 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31395267 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.31226100 |
| 113 | Focal adhesion_Homo sapiens_hsa04510 | 0.31225950 |
| 114 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.30972031 |
| 115 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29973073 |
| 116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29300396 |
| 117 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.28623718 |
| 118 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.28601378 |
| 119 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.28082893 |
| 120 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.27332101 |
| 121 | Endocytosis_Homo sapiens_hsa04144 | 0.25557488 |
| 122 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24905221 |
| 123 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23258461 |
| 124 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.20440501 |
| 125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20034761 |
| 126 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.19963967 |
| 127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.16934160 |
| 128 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.16605256 |

